Avid Bioservices, Inc. financial data

Symbol
CDMO on Nasdaq
Industry
Pharmaceutical Preparations
Location
14191 Myford Road, Tustin, California
State of incorporation
Delaware
Fiscal year end
April 30
Former names
PEREGRINE PHARMACEUTICALS INC (to 12/26/2017), TECHNICLONE CORP/DE/ (to 7/31/2000), TECHNICLONE INTERNATIONAL CORP (to 2/11/1997)
Latest financial report
Q4 2023 - Apr 24, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 48.5 % -52.9%
Quick Ratio 18.3 % -19.2%
Debt-to-equity 143 % -2.36%
Return On Equity -9.68 % -115%
Return On Assets -3.98 % -115%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 63.5 M shares +1.49%
Common Stock, Shares, Outstanding 63.5 M shares +1.5%
Entity Public Float 887 M USD -53.3%
Common Stock, Value, Issued 63 K USD +1.61%
Weighted Average Number of Shares Outstanding, Basic 63.3 M shares +1.5%
Weighted Average Number of Shares Outstanding, Diluted 63.3 M shares -8.45%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 137 M USD -2.81%
Costs and Expenses 27.5 M USD -4.01%
Operating Income (Loss) -16.6 M USD -531%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -21.1 M USD -1398%
Income Tax Expense (Benefit) -3.17 M USD +97.2%
Net Income (Loss) Attributable to Parent -18 M USD -115%
Earnings Per Share, Basic -0.28 USD/shares -115%
Earnings Per Share, Diluted -0.28 USD/shares -117%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 30.7 M USD -48.7%
Marketable Securities, Current 4.8 M USD
Accounts Receivable, after Allowance for Credit Loss, Current 18.5 M USD +25%
Inventory, Net 34.6 M USD -23.4%
Assets, Current 104 M USD -21.7%
Deferred Income Tax Assets, Net 118 M USD +2.64%
Property, Plant and Equipment, Net 188 M USD +14.1%
Operating Lease, Right-of-Use Asset 41.6 M USD +20.6%
Other Assets, Noncurrent 4.71 M USD +6.97%
Assets 455 M USD +0.99%
Accounts Payable, Current 19.5 M USD -46.4%
Employee-related Liabilities, Current 4.11 M USD -51.1%
Contract with Customer, Liability, Current 52.9 M USD +40.3%
Liabilities, Current 223 M USD -2.37%
Operating Lease, Liability, Noncurrent 44.7 M USD +25.3%
Liabilities 275 M USD +3.54%
Retained Earnings (Accumulated Deficit) -449 M USD -4.18%
Stockholders' Equity Attributable to Parent 180 M USD -2.67%
Liabilities and Equity 455 M USD +0.99%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -236 K USD +95.4%
Net Cash Provided by (Used in) Financing Activities 748 K USD -19.5%
Net Cash Provided by (Used in) Investing Activities -14.2 M USD -106%
Common Stock, Shares Authorized 150 M shares 0%
Common Stock, Shares, Issued 63.5 M shares +1.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 30.7 M USD -49%
Interest Paid, Excluding Capitalized Interest, Operating Activities 27 K USD +17.4%
Deferred Tax Assets, Valuation Allowance 0 USD
Deferred Tax Assets, Gross 140 M USD +9.91%
Payments to Acquire Property, Plant, and Equipment 14.2 M USD +106%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -18 M USD -115%
Property, Plant and Equipment, Gross 226 M USD +17%
Operating Lease, Liability, Current 1.31 M USD -56.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +90.9%
Deferred Income Tax Expense (Benefit) -620 K USD -210%
Deferred Tax Assets, Operating Loss Carryforwards 112 M USD +12.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5 M shares 0%
Operating Lease, Payments 1.12 M USD +16.2%
Additional Paid in Capital 629 M USD +2.12%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 276 K USD -54.4%
Depreciation, Depletion and Amortization 2.65 M USD +66.6%
Deferred Tax Assets, Net of Valuation Allowance 140 M USD +9.91%
Interest Expense 3.19 M USD +9.52%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%